Leukemia, Myelodysplasia, Transplantation
From the Journals
COVID-19 impact: Less chemo, immune checkpoint inhibitors, and steroids
A survey finds the COVID-19 pandemic to have a significant impact on oncologists’ decision-making.
From the Journals
Polygenic risk score may predict VTE in adolescents, but not adults, with ALL
From the Journals
BALL score predicts benefit from ibrutinib therapy in relapsed/refractory CLL patients
From the Journals
Posaconazole prophylaxis was effective in children with ALL undergoing chemotherapy
Targeted posaconazole prophylaxis was effective in preventing invasive fungal infection in children with ALL undergoing induction chemotherapy.
From the Journals
Hepatitis screening now for all patients with cancer on therapy
All patients with cancer who are candidates for systemic therapy should be screened for hepatitis B, says the American Society of Clinical...
Feature
ASCO says ‘no’ to home infusions of cancer treatment, with exceptions
The American Society of Clinical Oncology has warned against intravenous infusion of chemotherapy and monoclonal antibodies in cancer patients’...
From the Journals
OK to treat many cancer patients despite pandemic, says ESMO
ESMO recommends against stopping or delaying cancer treatment that can impact survival.
Conference Coverage
CCC19, other registries help define COVID/cancer landscape
New data from CCC19 show an increased risk of death from COVID-19 among non-Hispanic black cancer patients and patients with hematologic...
Feature
In remission for 10 years: Long-term toxicity data on CAR T cells
Latest News
Don’t overlook treating older patients with acute promyelocytic leukemia, expert says
“Management options have changed dramatically with the advent of non–chemotherapy-based regimens.”
News
FDA approves oral therapy for myelodysplastic syndromes, CMML
Under a priority review, the FDA approved a combination tablet for treatment of people with myelodysplastic syndromes or chronic myelomonocytic...